KR20080052827A - B형 간염 치료제 클레부딘의 개선된 제조방법 - Google Patents
B형 간염 치료제 클레부딘의 개선된 제조방법 Download PDFInfo
- Publication number
- KR20080052827A KR20080052827A KR1020060124497A KR20060124497A KR20080052827A KR 20080052827 A KR20080052827 A KR 20080052827A KR 1020060124497 A KR1020060124497 A KR 1020060124497A KR 20060124497 A KR20060124497 A KR 20060124497A KR 20080052827 A KR20080052827 A KR 20080052827A
- Authority
- KR
- South Korea
- Prior art keywords
- benzoyl
- clevudine
- alkali metal
- metal salt
- deoxy
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
Abstract
Description
d-space | 상대적인 강도 | 2θ 각도 |
6.7375 | 26 | 13.140 |
5.3402 | 31 | 16.600 |
4.5108 | 50 | 19.680 |
4.2745 | 100 | 20.780 |
3.9864 | 33 | 22.300 |
3.3460 | 24 | 26.640 |
3.1622 | 25 | 28.220 |
2.8488 | 70 | 31.400 |
파장(cm-1) | 기여 |
1650 - 1680 | C=O 신축 |
2800 - 3000 | N-H 신축 |
3300 - 3500 | O-H 신축 |
화합물 | 종래 방법 | 본 발명의 방법 |
불소반응에서 CTBR 생성비율 | 0.7% | 0.4% |
탈보호공정 반응 시간 | 72시간 | 12시간 |
총수율(ITBR부터) | 38.9% | 43.2% |
Claims (8)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060124497A KR100839322B1 (ko) | 2006-12-08 | 2006-12-08 | B형 간염 치료제 클레부딘의 개선된 제조방법 |
PCT/KR2007/005441 WO2008069451A1 (en) | 2006-12-08 | 2007-10-31 | Improved process for the preparation of clevudine as anti-hbv agent |
JO2007521A JO2677B1 (en) | 2006-12-08 | 2007-12-06 | Improved process for the preparation of the clevudine compound as an anti-HBV agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060124497A KR100839322B1 (ko) | 2006-12-08 | 2006-12-08 | B형 간염 치료제 클레부딘의 개선된 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080052827A true KR20080052827A (ko) | 2008-06-12 |
KR100839322B1 KR100839322B1 (ko) | 2008-06-17 |
Family
ID=39492283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060124497A KR100839322B1 (ko) | 2006-12-08 | 2006-12-08 | B형 간염 치료제 클레부딘의 개선된 제조방법 |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100839322B1 (ko) |
JO (1) | JO2677B1 (ko) |
WO (1) | WO2008069451A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105943547B (zh) * | 2016-05-23 | 2018-01-19 | 北京慧宝源生物技术股份有限公司 | 抗hbv的药物组合物及其应用 |
CN106831901A (zh) * | 2016-12-14 | 2017-06-13 | 安徽省诚联医药科技有限公司 | 2‑脱氧‑2‑氟‑1,3,5‑三苯甲酰基‑α‑D‑阿拉伯呋喃糖的制备方法 |
CN109467583A (zh) * | 2018-11-17 | 2019-03-15 | 扬州工业职业技术学院 | 一种克拉夫定的绿色合成工艺 |
-
2006
- 2006-12-08 KR KR1020060124497A patent/KR100839322B1/ko active IP Right Grant
-
2007
- 2007-10-31 WO PCT/KR2007/005441 patent/WO2008069451A1/en active Application Filing
- 2007-12-06 JO JO2007521A patent/JO2677B1/en active
Also Published As
Publication number | Publication date |
---|---|
WO2008069451A1 (en) | 2008-06-12 |
JO2677B1 (en) | 2013-03-03 |
KR100839322B1 (ko) | 2008-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111205294A (zh) | 一种瑞德西韦中间体的制备方法 | |
US8193354B2 (en) | Process for preparation of Gemcitabine hydrochloride | |
JP2005139197A (ja) | 5−メチルウリジンを用いる2’,3’−ジデヒドロ−3’−デオキシチミジン(d4T)の製法 | |
AU2008327061B2 (en) | Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein | |
US9834561B2 (en) | Process for preparing ibrutinib and its intermediates | |
KR100839322B1 (ko) | B형 간염 치료제 클레부딘의 개선된 제조방법 | |
JP3677790B2 (ja) | ヌクレオシド誘導体とその製造方法 | |
EP1405857B1 (en) | Process for the production of 2-methyl-(3,4,6-tri-O-acetyl-1,2-dideoxy-alpha-glucopyrano)-[2,1-d]-2-oxazoline | |
CN111471070B (zh) | 瑞德西韦的合成方法 | |
KR20040031784A (ko) | L-리바비린의 제조 방법 | |
US7388094B2 (en) | Processing for producing 2′-deoxy-2′-fluorouridine | |
JP6947354B2 (ja) | リナグリプチンの製造法 | |
US7361745B2 (en) | Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives | |
EP0350292A2 (en) | Process for preparing 2'-deoxy-beta-adenosine | |
KR101259648B1 (ko) | 2′,2′-디플루오로뉴클레오시드 및 중간체의 새로운 제조방법 | |
JP2004323518A (ja) | 2’−デオキシ−2’−フルオロウリジンの製造方法 | |
KR101628946B1 (ko) | 실로도신의 개선된 제조방법 | |
CN112979736B (zh) | 一种瑞德西韦的制备方法 | |
US20090018325A1 (en) | Process for preparing l-nucleic acid derivatives and intermediates thereof | |
JPH06135988A (ja) | ヌクレオシド誘導体 | |
EP0495225A1 (en) | Process for the preparation of 3'fluoropyrimidine nucleosides | |
US7214791B2 (en) | Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material | |
KR100528703B1 (ko) | 5'-데옥시-5-플루오로우리딘의제조방법 | |
JPH0597847A (ja) | 核酸化合物の新規な製造方法 | |
AU2005275935A1 (en) | Method for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130422 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140403 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160610 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170412 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180412 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190327 Year of fee payment: 12 |